J. Matthews

1.6k citations

20 papers · 1.1k indexed · h-index 13

Co-authors: A. J. Norton J. Amess Peter Johnson A. Z. S. Rohatiner Tim Lister Jeremy Whelan C. G. A. Price Sharon Love
Topics: Lymphoma Diagnosis and Treatment (19 papers)Viral-associated cancers and disorders (11 papers)Chronic Lymphocytic Leukemia Research (11 papers)
Cited by: Pathology and Forensic Medicine Genetics Oncology
Journals: Journal of Clinical Oncology Blood British Journal of Cancer
Partner nations: United Kingdom Switzerland United States

In The Last Decade

J. Matthews

20 papers receiving 1.1k citations

Peers

Countries citing papers authored by J. Matthews

Since Specialization

Citations

This map shows the geographic impact of J. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Matthews more than expected).

Fields of papers citing papers by J. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Matthews. The network helps show where J. Matthews may publish in the future.

Co-authorship network of co-authors of J. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of J. Matthews. A scholar is included among the top collaborators of J. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Matthews. J. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Life expectancy of young adults with follicular lymphoma 2015 ·Annals of Oncology ·Annarita Conconi,Chiara Lobetti‐Bodoni,Silvia Montoto,Armando López‐Guillermo,Rita Coutinho,J. Matthews,Silvia Franceschetti,Francesco Bertoni,Alden A. Moccia,Paola M. V. Rancoita,John G. Gribben,Franco Cavalli,Gianluca Gaïdano,T. Andrew Lister,Emili Montserrat,Michele Ghielmini,Emanuele Zucca	27
2	Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP 2014 ·Haematologica ·Rita Coutinho,Andrew Clear,Emanuele Mazzola,Andrew Owen,Paul Greaves,Andrew Wilson,J. Matthews,Alexander Lee,Ricardo Alvarez,María Gomes da Silva,José Cabeçadas,Donna Neuberg,Mariarita Calaminici,John G. Gribben	48
3	Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse 2012 ·Haematologica ·Silvia Montoto,J. Matthews,Paul Greaves,Debra M. Lillington,(unknown),John G. Gribben,Tim Lister	9
4	Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management 2010 ·Haematologica ·Marco Gerlinger,A. Z. S. Rohatiner,J. Matthews,Andrew Davies,Tim Lister,Silvia Montoto	9
5	Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma 2007 ·Leukemia ·Jude Fitzgibbon,Sameena Iqbal,Andrew Davies,Derville O’Shea,Emanuela Carlotti,Tracy Chaplin,J. Matthews,Manoj Raghavan,A. J. Norton,T. Andrew Lister,Bryan D. Young	55
6	Preliminary Results of a Phase I/II Study of Weekly or Twice Weekly Bortezomib in Combination with Rituximab, in Patients with Follicular Lymphoma, Mantle Cell Lymphoma and Waldenstrom’s Macroglobulinaemia. 2007 ·Blood ·(unknown),Simon Rule,Peter Johnson,John Radford,(unknown),Hannah Hunter,Jaclyn P. Kerr,(unknown),J. Matthews,Sandra J. Strauss,Silvia Montoto,A. Z. S. Rohatiner,Tim Lister	10
7	Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: A two-institution study 2003 ·Seminars in Oncology ·Magnus Björkholm,Emma Johansson,D. Papamichael,Fredrik Celsing,J. Matthews,Tim Lister,A. Z. S. Rohatiner	33
8	Waldenstrom's macroglobulinemia: A retrospective analysis of 40 patients from 1972 to 2001 2003 ·Seminars in Oncology ·Samuel Y. Ngan,A. Z. S. Rohatiner,J. Matthews,Alan Williams,J. Amess,A. J. Norton,Tim Lister	3
9	Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia 2002 ·Annals of Oncology ·Debra M. Lillington,Ivana N. Micallef,(unknown),Michael Neat,J. Amess,J. Matthews,Natalie J. Foot,T. Andrew Lister,Bryan D. Young,A. Z. S. Rohatiner	10
10	A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma 2000 ·Annals of Oncology ·Charles Crawley,James M. Foran,Rajnish K. Gupta,A. Z. S. Rohatiner,Karin E. Summers,J. Matthews,Ivana N. Micallef,John Radford,S.A. Johnson,Peter Johnson,John Sweetenham,T. Andrew Lister	40
11	Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response 2000 ·Annals of Oncology ·James M. Foran,David Cunningham,Bertrand Coiffier,Philippe Solal‐Céligny,F Reyes,Michele Ghielmini,Peter Johnson,Christian Gisselbrecht,Mike Bradburn,J. Matthews,Tim Lister	90
12	Patterns of Outcome Following Recurrence After Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma 1999 ·Journal of Clinical Oncology ·John Apostolidis,James M. Foran,Peter Johnson,A. J. Norton,J. Amess,J. Matthews,Mike Bradburn,Tim Lister,A. Z. S. Rohatiner	40
13	High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre 1998 ·Annals of Oncology ·James M. Foran,John Apostolidis,D. Papamichael,A. J. Norton,J. Matthews,J. Amess,Tim Lister,A. Z. S. Rohatiner	67
14	Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period 1995 ·Annals of Oncology ·A. J. Norton,J. Matthews,Vasiliki Pappa,Jonathan Shamash,Seth Love,A. Z. S. Rohatiner,T. Lister	131
15	Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. 1995 ·Journal of Clinical Oncology ·Peter Johnson,A. Z. S. Rohatiner,Jeremy Whelan,C. G. A. Price,Sharon Love,Jerian F. Lim,J. Matthews,A. J. Norton,J. Amess,Tim Lister	265
16	Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. 1994 ·Journal of Clinical Oncology ·A. Z. S. Rohatiner,Peter Johnson,C. G. A. Price,S.J. Arnott,J. Amess,A. J. Norton,E. Dorey,K. Adams,Jeremy Whelan,J. Matthews	199
17	Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma 1993 ·British Journal of Cancer ·Harpal S. Dhaliwal,(unknown),Walter M. Gregory,M A Richards,(unknown),(unknown),(unknown),J. Matthews,TS Ganesan,Michael J. Barnett,Jonathan Waxman,A G Stansfeld,P. F. M. Wrigley,Mark Slevin,J. S. Malpas,(unknown)	34
18	β-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas 1993 ·British Journal of Cancer ·(unknown),Jeremy Whelan,(unknown),Kasia Stepniewska,J. Matthews,J. Amess,A. J. Norton,(unknown),TA Lister	40
19	Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy 1992 ·Hematological Oncology ·Jeremy Whelan,Catherine L. Davis,A. Z. S. Rohatiner,Martin J. Leahy,Peter K. MacCallum,Rajnish K. Gupta,J. Matthews,A. J. Norton,J. Amess,Tim Lister	6
20	Prognostic value of cytophotometric analysis of DNA in lymph node aspirates from patients with non-Hodgkin's lymphoma. 1990 ·Journal of Clinical Pathology ·(unknown),(unknown),J. Matthews,S. N. Wickramasinghe,Mara Dominis,(unknown)	6

About J. Matthews

J. Matthews is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (988 citations), Genetics (428 citations) and Oncology (664 citations). J. Matthews has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include A. J. Norton, J. Amess, Peter Johnson, A. Z. S. Rohatiner, Tim Lister, Jeremy Whelan, C. G. A. Price, A. Z. S. Rohatiner, Sharon Love and Jerian F. Lim. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact